BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for May 9, 2024

May 9, 2024
New hires and promotions in the biopharma industry, including: Merakris.
Read More

Appointments and advancements for May 9, 2024

May 9, 2024
New hires and promotions in the med-tech industry, including: Apyx Medical, Boston Scientific, Carna Health, Imunon, Pelvital, R3 Vascular.
Read More

Appointments and advancements for May 8, 2024

May 8, 2024
New hires and promotions in the biopharma industry, including: Advancell, Alcyone, DBV, Eterna, Hutchmed, Imunon, Kancera, Neurenati, Obsidian, Relief, Tolremo, Tyra.
Read More

Appointments and advancements for May 8, 2024

May 8, 2024
New hires and promotions in the med-tech industry, including: Cagent Vascular, Diality, Hutchmed, ITM Isotope, Lucid Diagnostics, Neurocare.
Read More

Appointments and advancements for May 7, 2024

May 7, 2024
New hires and promotions in the biopharma industry, including: ALX Oncology, Atopia, Cellarity, ITM, Nimbus, Palisade, Seaport, Topas.
Read More

Appointments and advancements for May 7, 2024

May 7, 2024
New hires and promotions in the med-tech industry, including: Beaconcure, Blackwell Security, Celerion, Cagent Vascular, Crm Surgical, Otolith Labs, Sapient, Trisalus.
Read More

Appointments and advancements for May 6, 2024

May 6, 2024
New hires and promotions in the biopharma industry, including: Genenta, Ratio, Sagimet.
Read More

Appointments and advancements for May 3, 2024

May 3, 2024
New hires and promotions in the biopharma industry, including: Cellectis, Vor.
Read More

Appointments and advancements for May 3, 2024

May 3, 2024
New hires and promotions in the med-tech industry, including: Karius, Probo Medical.
Read More

Appointments and advancements for May 2, 2024

May 2, 2024
New hires and promotions in the biopharma industry, including: Aprea, Iktos, Immunome, Ipsen, Journey Medical, Nvelop, PDS, Pluri, Rentschler, Shape, Vicinitas.
Read More
Previous 1 2 … 96 97 98 99 100 101 102 103 104 … 329 330 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 31, 2026.
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • Anthony Fauci at Senate hearing 7-29

    Fauci’s silence may put him in contempt of Congress

    BioWorld
    After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...
  • Mitochondria

    Seed funding at Adjuvia to treat mitochondrial dysfunction

    BioWorld Science
    Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing